Exploiting liver immunity for the prevention of hepatic metastases

Journal of Hepatology

Volumn 53, Issue 4, 2010, Pages 596-598

  Rivoltini, Licia ^a   Mazzaferro, Vincenzo ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; CANCER VACCINE; CD8 ANTIGEN; CHEMOKINE; CYTOKINE; EPIDERMAL GROWTH FACTOR RECEPTOR; GROWTH FACTOR; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 96; TRASTUZUMAB; UNCLASSIFIED DRUG; VASCULOTROPIN ANTIBODY;

ADOPTIVE IMMUNOTHERAPY; ADOPTIVE TRANSFER; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTINEOPLASTIC ACTIVITY; CANCER CELL CULTURE; CANCER GROWTH; CANCER IMMUNIZATION; CANCER SURVIVAL; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; COLORECTAL CANCER; COLORECTAL CARCINOMA; CYTOTOXIC T LYMPHOCYTE; EDITORIAL; GRANULOCYTE; HUMAN; INNATE IMMUNITY; KUPFFER CELL; LIVER METASTASIS; LIVER PROTECTION; MACROPHAGE; MONOCYTE; NATURAL KILLER CELL; NONHODGKIN LYMPHOMA; PORTAL VEIN BLOOD FLOW; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SUPPRESSOR CELL; T LYMPHOCYTE ACTIVATION; TUMOR IMMUNITY;

CANCER VACCINES; HUMANS; IMMUNITY, INNATE; IMMUNOTHERAPY; LIVER NEOPLASMS; NEOPLASM METASTASIS;

EID: 77956266462     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2010.06.001     Document Type: Editorial

References (22)

1. O. Finn Molecular origin of cancer. Cancer immunology N Engl J Med 358 2008 2704 2715
2. M.A. Morse, and M. Whelan A year of successful cancer vaccines points to a path forward Curr Opin Mol Ther 12 2010 11 13
3. M. Campoli, R. Ferris, S. Ferrone, and X. Wang Immunotherapy of malignant disease with tumor antigen-specific monoclonal antibodies Clin Cancer Res 16 2010 11 20
4. S.A. Rosenberg, N.P. Restifo, J.C. Yang, R.A. Morgan, and M.E. Dudley Adoptive cell transfer: a clinical path to effective cancer immunotherapy Nat Rev Cancer 8 2008 299 308
5. L.M. Weiner, R. Surana, and S. Wang Monoclonal antibodies: versatile platforms for cancer immunotherapy Nat Rev Immunol 10 2010 317 327
6. N.L. Spector, and K.L. Blackwell Understanding the mechanisms behind trastuzumab therapy for human epidermal growth factor receptor 2-positive breast cancer J Clin Oncol 27 2009 5838 5947
7. R. Bargou, E. Leo, G. Zugmaier, M. Klinger, M. Goebeler, and S. Knop Tumor regression in cancer patients by very low doses of a T cell-engaging antibody Science 321 2008 974 977
8. F. Pags, A. Kirilovsky, B. Mlecnik, M. Asslaber, M. Tosolini, and G. Bindea In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer J Clin Oncol 27 2009 5944 5951
9. L. Rivoltini, P. Canese, V. Huber, M. Iero, L. Pilla, and R. Valenti Escape strategies and reasons for failure in the interaction between tumour cells and the immune system: how can we tilt the balance towards immune-mediated cancer control? Expert Opin Biol Ther 5 2005 463 476
10. D.I. Gabrilovich, and S. Nagaraj Myeloid-derived suppressor cells as regulators of the immune system Nat Rev Immunol 9 2009 162 174
11. Van der Bij GJ, Bogels M, Otten MA, et al. Enhanced outgrowth of liver metastases after abdominal surgical trauma is prevented by mononuclear phagocyte-mediated monoclonal antibody therapy. J Hepatol present issue.
12. E. Tagliabue, R. Agresti, M.L. Carcangiu, C. Ghirelli, D. Morelli, and M. Campiglio Role of HER2 in wound-induced breast carcinoma proliferation Lancet 362 2003 527 533
13. M.A. Troester, M.H. Lee, M. Carter, C. Fan, D.W. Cowan, and E.R. Perez Activation of host wound responses in breast cancer microenvironment Clin Cancer Res 15 2009 7020 7028
14. I.N. Crispe The liver as a lymphoid organ Annu Rev Immunol 27 2009 147 163
15. E. Nemeth, A.W. Baird, and C. O'Farrelly Microanatomy of the liver immune system Semin Immunopathol 31 2009 333 343
16. M. van Egmond, E. van Garderen, A.B. van Spriel, C.A. Damen, E.S. van Amersfoort, and G. van Zandbergen FcαRI-positive liver Kupffer cells: reappraisal of the function of immunoglobulin A in immunity Nat Med 6 2000 680 685
17. J. Mestas, and C.C. Hughes Of mice and not men: differences between mouse and human immunology J Immunol 172 2004 2731 2738
18. G. Panter, A. Kuznik, and R. Jerala Therapeutic applications of nucleic acids as ligands for Toll-like receptors Curr Opin Mol Ther 11 2009 133 145
19. M.A. Hollingsworth, and B.J. Swanson Mucins in cancer: protection and control of the cell surface Nat Rev Cancer 4 2004 45 60
20. F.F. Liu, X.Y. Dong, X.W. Pang, Q. Xing, H.C. Wang, and H.G. Zhang The specific immune response to tumor antigen CP1 and its correlation with improved survival in colon cancer patients Gastroenterology 134 2008 998 1006
21. V. Mazzaferro, J. Coppa, M.G. Carrabba, L. Rivoltini, M. Schiavo, and E. Regalia Vaccination with autologous tumor-derived heat-shock protein gp96 after liver resection for metastatic colorectal cancer Clin Cancer Res 9 2003 3235 3245
22. L. Pilla, P. Squarcina, J. Coppa, V. Mazzaferro, V. Huber, and D. Pende Natural killer and NK-Like T-cell activation in colorectal carcinoma patients treated with autologous tumor-derived heat shock protein 96 Cancer Res 65 2005 3942 3949